Tripling margins is not enough on the ASX

ResMed's margins have almost tripled over the past quarter...

[TV bullets, seen here: https://ausbiz.com.au/media/market-update-anz-coles-resmed-qantas-evolution-mining-collins-food?videoId=48271]

Indeed, the medical devices company has seen gross margin expand by 290 basis points to 62.2 per cent.

Meanwhile... third quarter revenue were up 8 per cent on a constant currency basis, reaching 1.4 billion dollars.

[Stock price]

And ResMed says it has returned 262 million dollars to shareholders through share repurchases and dividends.

For the past quarter, shareholders will receive a 60 cents dividend per share.

However, the share price is lower today... with CFO Brett Sandercock retiring, and device growth in the Americas missing expectations.